Clinical Utility of Acute-phase Reactants in Medicine

Pratap Signh, Sanjay Kumar, Mukesh Verma, Subodh kumar Mahto

Abstract


Acute-phase response is the sum of the systemic and metabolic changes occurred by release of acute-phase proteins in response to an inflammatory stimulus. The most important ones of these acute-phase reactants are erythrocyte sedimentation rate, C-reactive protein, fibrinogen, procalcitonin and ferritin. The most widely used ones are ESR and CRP while fibrinogen and ferritin are less commonly used. The other acute-phase reactants have limited role in routine clinical use. ESR and C-reactive protein have traditionally been used as markers for inflammation in infectious and noninfectious conditions. These markers have significant role in early diagnosis, in differentiating infectious from noninfectious causes, as a prognostic marker and in antibiotic guidance strategies. Procalcitonin and CRP are most commonly used in this regard. Although CRP is more specific than ESR, yet because of the high cost and limited availability, it has restricted clinical usage in developing countries. Not all acute-phase reactants behave the same way when stimulated; the concentration of some increases while others decrease in plasma.


Keywords


Acute-phase reactants, Erythrocyte sedimentation rate, C-reactive protein, Fibrinogen, Ferritin, Procalcitonin

Full Text:

PDF

References


Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med Feb 1999; 340(6): 448-54. 2. International Council for Standardization in Haematology (Expert Panel on Blood Rheology). ICSH recommendations for measurement of erythrocyte sedimentation rate. J Clin Pathol 1993; 46: 198-208. 3. Pepys MB, Baltz ML. Acute-phase proteins with special reference to C-Reactive protein and related proteins and serum amyloid A proteins. Adv Immunol 1983; 34: 141-42. 4. Pepys MB, Gideon MH. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-11. 5. King VL, Thompson J, Tannock LR. Serum amyloid A in atherosclerosis. Current Opinion in Lipidology 2011; 22(4): 302-307. 6. Koperdanova M, Cullis JO. Interpreting raised serum ferritin levels. BMJ 2015; 351: 31-33. 7. Casl MT, Bulatovic G, Orlic P et al. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection. Nephrology Dialysis Transplantation 1995; 10(10): 1901-904. 8. Dean MM, Minchinton RM, Heatley S et al. Mannose binding lectin acute-phase activity in patients with severe infection. J Clin Immunol Jul 2005; 25(4): 346-52.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Advanced Research in Medicine